Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
784 Immune profiling of patients with advanced melanoma intratumorally treated with CV8102 as a single-agent or in combination with anti-PD-1 antibodies – results of a phase I trial expansion
Compose a Response to This Article
Other responses
No responses have been published for this article.